HealthWell Foundation Launches Waldenstrom Macroglobulinemia Fund
Retrieved on:
Wednesday, December 14, 2022
Newton, Spleen, Lymphatic system, Immune system, Disease management, Weakness, IWMF, Charitable organization, Patient, Waldenström's macroglobulinemia, WM, Waldenström, Fatigue, Lymph, Liver, Disease, Quality of life, Abdomen, Caregiver, Safety, Hyperviscosity syndrome, Common, Infection, Macroglobulinemia, Blood, Insurance, Health insurance, Pharmaceutical industry, Residential care
GERMANTOWN, Md., Dec. 14, 2022 /PRNewswire/ -- The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is proud to announce that it has launched a new fund to provide financial assistance to patients living with Waldenstrom Macroglobulinemia. Through the new fund, HealthWell will provide up to $8,000 in copayment or insurance premium assistance to eligible patients with annual household incomes up to 500 percent of the federal poverty level to obtain prescription medications for the treatment and management of their condition.
Key Points:
- GERMANTOWN, Md., Dec. 14, 2022 /PRNewswire/ -- The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, is proud to announce that it has launched a new fund to provide financial assistance to patients living with Waldenstrom Macroglobulinemia.
- Waldenstrom macroglobulinemia (WM) is a rare type of blood cancer that begins in the white blood cells and is a slow-growing cancer of the lymphatic system.
- "We applaud the HealthWell Foundation and its donors for recognizing the undue financial burden patients face in accessing and affording their care.
- To determine eligibility and apply for financial assistance, visit HealthWell's Waldenstrom Macroglobulinemia Fund page.